HUMDF (Hua Medicine) Other Stockholders Equity : $38.89 Mil (As of Jun. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Hua Medicine Other Stockholders Equity?

Hua Medicine's Other Stockholders Equity for the quarter that ended in Jun. 2024 was $38.89 Mil.

Hua Medicine's quarterly Other Stockholders Equity increased from Jun. 2023 ($36.59 Mil) to Dec. 2023 ($38.44 Mil) and increased from Dec. 2023 ($38.44 Mil) to Jun. 2024 ($38.89 Mil).

Hua Medicine's annual Other Stockholders Equity declined from Dec. 2021 ($36.05 Mil) to Dec. 2022 ($36.00 Mil) but then increased from Dec. 2022 ($36.00 Mil) to Dec. 2023 ($38.44 Mil).

Hua Medicine Other Stockholders Equity Historical Data

The historical data trend for Hua Medicine's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hua Medicine Other Stockholders Equity Chart

Hua Medicine Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Stockholders Equity

Get a 7-Day Free Trial

19.69

30.06

36.05

36.00

38.44

Hua Medicine Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Other Stockholders Equity	Get a 7-Day Free Trial											53.86	36.00	36.59	38.44	38.89

Hua Medicine Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Hua Medicine Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Hua Medicine's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Hua Medicine Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hua Medicine (OTCPK:HUMDF) » Definitions » Other Stockholders Equity

Traded in Other Exchanges

02552:Hong Kong

Address

Lane 36, Xuelin Road, Hua Medicine, Building 2, Pudong New Area, Shanghai, CHN, 201203

Website

https://www.huamedicine.com

Hua Medicine is an investment holding company. It is engaged in the development and commercialization of a first-in-class oral drug, Dorzagliatin or HMS5552, for the treatment of Type 2 diabetes. The group majorly operates in the PRC.